These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27283831)

  • 41. Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers.
    Abnous K; Danesh NM; Ramezani M; Charbgoo F; Bahreyni A; Taghdisi SM
    Expert Opin Drug Deliv; 2018 Nov; 15(11):1045-1052. PubMed ID: 30269603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of epirubicin cytotoxicity by tamoxifen in human breast cancer cell lines.
    Azab SS; El-Demerdash E; Abdel-Naim AB; Youssef E; El-Sharkawy N; Osman AM
    Biochem Pharmacol; 2005 Sep; 70(5):725-32. PubMed ID: 16005435
    [TBL] [Abstract][Full Text] [Related]  

  • 43. pH-and thermo-sensitive pluronic/poly(acrylic acid) in situ hydrogels for sustained release of an anticancer drug.
    Lo YL; Hsu CY; Lin HR
    J Drug Target; 2013 Jan; 21(1):54-66. PubMed ID: 23009351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
    Moosavian SA; Abnous K; Badiee A; Jaafari MR
    Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new chemotherapy agent-free theranostic system composed of graphene oxide nano-complex and aptamers for treatment of cancer cells.
    Bahreyni A; Yazdian-Robati R; Hashemitabar S; Ramezani M; Ramezani P; Abnous K; Taghdisi SM
    Int J Pharm; 2017 Jun; 526(1-2):391-399. PubMed ID: 28495579
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery.
    Sayari E; Dinarvand M; Amini M; Azhdarzadeh M; Mollarazi E; Ghasemi Z; Atyabi F
    Int J Pharm; 2014 Oct; 473(1-2):304-15. PubMed ID: 24905777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeted imaging of breast cancer cells using two different kinds of aptamers -functionalized nanoparticles.
    Mohammadinejad A; Taghdisi SM; Es'haghi Z; Abnous K; Mohajeri SA
    Eur J Pharm Sci; 2019 Jun; 134():60-68. PubMed ID: 30970280
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
    Nasr M; Nafee N; Saad H; Kazem A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):216-25. PubMed ID: 24813390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 5TR1 aptamer-PEGylated liposomal doxorubicin enhances cellular uptake and suppresses tumour growth by targeting MUC1 on the surface of cancer cells.
    Moosavian SA; Abnous K; Akhtari J; Arabi L; Gholamzade Dewin A; Jafari M
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):2054-2065. PubMed ID: 29205059
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High payload and targeted release of anthracyclines by aptamer-tethered DNA nanotrains - Thermodynamic and release kinetic study.
    Pei W; Liu M; Wu Y; Zhao Y; Liu T; Sun B; Liu Y; Wang Q; Han J
    Eur J Pharm Sci; 2020 May; 148():105319. PubMed ID: 32205231
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A pH-sensitive DNA tetrahedron for targeted release of anthracyclines: Binding properties investigation and cytotoxicity evaluation.
    Weng T; Wang L; Zhang X; Wu Y; Zhao Y; Zhang Y; Han J; Liu M
    Int J Biol Macromol; 2022 Dec; 223(Pt A):766-778. PubMed ID: 36372106
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Construction and application of biotin-poloxamer conjugate micelles for chemotherapeutics.
    Lin GY; Lv HF; Lu CT; Chen LJ; Lin M; Zhang M; Zhao YZ; Su ZX; Shen XT; Jiang X; Jin RR; Li X
    J Microencapsul; 2013; 30(6):538-45. PubMed ID: 23489016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel chemotherapy drug-free delivery system composed of three therapeutic aptamers for the treatment of prostate and breast cancers in vitro and in vivo.
    Abnous K; Danesh NM; Ramezani M; Yazdian-Robati R; Alibolandi M; Taghdisi SM
    Nanomedicine; 2017 Aug; 13(6):1933-1940. PubMed ID: 28414074
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel FAPα-based Z-Gly-Pro epirubicin prodrug for improving tumor-targeting chemotherapy.
    Wang J; Li Q; Li X; Yuan W; Huang S; Cai S; Xu J
    Eur J Pharmacol; 2017 Nov; 815():166-172. PubMed ID: 28919026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancer.
    Gu X; Xue JQ; Han SJ; Qian SY; Zhang WH
    Cancer Biomark; 2016; 16(3):395-403. PubMed ID: 27062696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epirubicin-loaded marine carrageenan oligosaccharide capped gold nanoparticle system for pH-triggered anticancer drug release.
    Chen X; Han W; Zhao X; Tang W; Wang F
    Sci Rep; 2019 May; 9(1):6754. PubMed ID: 31043709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aptamer-guided DNA tetrahedron as a novel targeted drug delivery system for MUC1-expressing breast cancer cells in vitro.
    Dai B; Hu Y; Duan J; Yang XD
    Oncotarget; 2016 Jun; 7(25):38257-38269. PubMed ID: 27203221
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells.
    Li WM; Bing T; Wei JY; Chen ZZ; Shangguan DH; Fang J
    Biomaterials; 2014 Aug; 35(25):6998-7007. PubMed ID: 24857291
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of biodegradable polyesters with various microstructures for highly controlled release of epirubicin and cyclophosphamide.
    Żółtowska K; Piotrowska U; Oledzka E; Luchowska U; Sobczak M; Bocho-Janiszewska A
    Eur J Pharm Sci; 2017 Jan; 96():440-448. PubMed ID: 27742595
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of miR-155 in MCF-7 breast cancer cell line by gold nanoparticles functionalized with antagomir and AS1411 aptamer.
    Kardani A; Yaghoobi H; Alibakhshi A; Khatami M
    J Cell Physiol; 2020 Oct; 235(10):6887-6895. PubMed ID: 32003016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.